Test developers frustrated by FDA’s resistance to at-home testing
The surge of interest in testing for the COVID-19 pathogen has led to some innovative tests and test strategies, including at-home tests. However, the FDA has indicated that it is wary of both at-home testing and specimen collection in other than sup
0 Replies
